South Korea opens first theranostics center

Asan Medical Center leads the expansion and research of cancer-treating radiopharmaceuticals.

South Korea's Asan Medical Center (AMC) started fully operating the country’s first-ever Theranostics Center, which will expand technology and treatment of neuroendocrine tumours and prostate cancer, specifically with therapeutic radiopharmaceuticals.

Rooted in the words “therapy” and “diagnosis," Theranostics is the technology of diagnosing and treating cancer through radiopharmaceuticals. They are seen as an effective treatment against cancer, due to fewer side effects and immediate attachment to cancer cells.

ALSO READ: Twin Towers Medical Centre opens mobile clinic for Malaysia’s industry workers

Currently, a therapeutic radiopharmaceutical for neuroendocrine tumours is approved in Korea, whilst a similar treatment for prostate cancer is pending approval. Asan Medical Center is involved in the global clinical trials for radiopharmaceuticals.

The World Health Organization recorded more than 10 million new cases of cancer globally in 2020, with more than 10 million cancer-related deaths.

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit